Impact of the COVID-19 pandemic on hospitalizations with hepatocellular carcinoma in the United States
P Konyn, BJ Perumpail, K Wijarnpreecha… - Expert Review of …, 2024 - Taylor & Francis
Background We studied the temporal trends of hepatocellular carcinoma (HCC)-related
hospitalizations and potential predictors of in-hospital mortality around the COVID-19 …
hospitalizations and potential predictors of in-hospital mortality around the COVID-19 …
COVID‐19‐associated liver injury: Adding fuel to the flame
Y Wang, M Shen, Y Li, J Shao, F Zhang… - Cell Biochemistry …, 2023 - Wiley Online Library
COVID‐19 is mainly characterized by respiratory disorders and progresses to multiple organ
involvement in severe cases. With expansion of COVID‐19 and SARS‐CoV‐2 research …
involvement in severe cases. With expansion of COVID‐19 and SARS‐CoV‐2 research …
Impact of COVID-19 vaccination on liver transplant recipients. Experience in a reference center in Mexico
D Azamar-Llamas, JS Arenas-Martinez… - Plos one, 2024 - journals.plos.org
Background and aims COVID-19 vaccination has proved to be effective to prevent
symptomatic infection and severe disease even in immunocompromised patients including …
symptomatic infection and severe disease even in immunocompromised patients including …
[PDF][PDF] Postoperative care of hepatocellular carcinoma patients based on enhanced recovery after surgery
W Song, D Liu, Y Zhou, J Jiang - Journal of Biotech Research …, 2024 - btsjournals.com
Hepatocellular carcinoma is the most common primary liver cancer worldwide with high
morbidity and mortality, which seriously threatens the life and health of human beings. In the …
morbidity and mortality, which seriously threatens the life and health of human beings. In the …